- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
mCare Labs, a newly formed start-up based in San Francisco USA, aims to build the next-generation infrastructure for pervasive mobile healthcare services.
Todays medical infrastructure entails some major limitations and challenges.
First, the current medical infrastructure is inefficient and leads to inflated costs for overall patient care. Because chronically-ill and hospitalized patients are often tethered to instrumentation, available medical capacity is severely restricted and rarely, if ever, efficiently utilized.
Second, decades-old medical systems in-place does not help either as the patient quality-of-care also does not improve.
Finally, current-generation medical systems were not designed to exploit the future medical advances such as in: microchip technology; remotely-controlled wireless devices implanted within the body and operated at the molecular level; or, advances in nanotechnology, biosciences, bioengineering, biochemistry and biotechnology that hold the promise of an ever-expanding pool of medical knowledge in these disciplines.
mCare Labs is rethinking the evolution of future medical services by building the next-generation infrastructure for pervasive mobile healthcare services. The aims are: (1) to dramatically reduce the medical costs for patient care, (2) to significantly increase the medical capacity and enhance the patient quality-of-service, and, (3) to create a flexible 'standard-based' medical ecosytem that help exploit future medical advances and also support mobile healthcare providers and clinical device vendors.
mCare Labs is building a small team to demonstrate the next-generation mobile medical services through a 'proof-of-concept' prototype.
About mCare Labs
mCare Labs is building the next-generation infrastructure for pervasive mobile healthcare services. Founded in 2009, mCare Labs is based in San Francisco CA, USA.
For more information, please click here
Copyright © NewswireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015